Emulate, Inc. is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, and testing how different medicines, chemicals, and foods affect human health. Emulate has also worked with Cedars-Sinai Medical Center on a precision medicine initiative that uses Organs-on-Chips technology in the clinical setting.

Emulate, Inc.

Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. 

Research conducted using our Organ-Chips has been published in high-impact scientific journals, including Science. In addition, Organ-Chips have been acquired by the Museum of Modern Art (MoMA) in New York for their permanent collection and have also been awarded Product Design of the Year 2015 by London’s Design Museum.

Alumni Ventures

SciFi VC

Beyond Impact Advisors

Glass Wall Syndicate

Founders Fund

ALS Investment Fund

Starlight Ventures

Northpond Ventures

Perceptive Advisors

Ethos Family Office

Prof. Hazel Screen from QMUL School of Engineering joined Operation Ouch to unravel the wonders of Organ-on-a-Chip technology for a younger audience, introducing a new generation to the power of human-relevant in vitro models. Learn more in this exclusive Q&A! https://bit.ly/47OdTHB

And the #MicroscopyMonday post with the most votes in 2023 is… this Alveolus Lung-Chip image! Using a Chip-A1 prototype, scientists grew alveolar cells on top of a stromal compartment, resulting in this supernova-like biology. Learn more about the Chip-A1: https://bit.ly/48rxwpz #OrganChips #Research

We are excited to announce that the University of St Andrews has been selected as the winner of the Emulate Infectious Disease Grant! This collaborative group of researchers will be applying Emulate Organ-on-a-Chip technology to help further their understanding of how viruses, bacteria, and parasites cause infection and disease as well as how these infectious diseases can be prevented and treated.

Coming in at second-place for 2023, this #MicroscopyMonday image shows strong barrier formation of colon epithelial cells (yellow ZO-1 staining) on a Colon Intestine-Chip prepared for immune cell recruitment (ICR). Learn more on our ICR application here: https://bit.ly/48nROQF

Over the next 3 weeks, we’re bringing back the most popular #MicroscopyMonday posts of 2023! Up first: Scientists developed a Skin-Chip model using the new Emulate Chip-A1 Accessible Chip, allowing them to capture these detailed images of the epidermis and fibroblasts within the 3D chamber. Join the Chip-A1 early access program now: https://bit.ly/3GFLE2K #OrganChips #Research #DrugDevelopment

COM:EMULATEBIO

Emulate, Inc.

name

homepage url

country

linkedin url

crunchbase url

employee count

sector

industry

Description

investor of

competitor of

Metrics